Blog

Cannabis & the Law

Foley Hoag has been at the forefront of the medical and adult-use cannabis industry since the very early stages of its regulation and legalization in specific U.S. states and beyond. Our leading, full-service Cannabis Practice is comprised of attorneys with unique insight and experience to assist cannabis and cannabis-related operators and investors with all aspects of their business. Our practice is national and international in scope, as we represent cannabis clients in transactions in a variety of states and Canada.

Barr Proposal To Legalize and Regulate Hemp-Derived Consumer Products Enters Crowded Field of Hemp Legislation
Blog June 03, 2026
After months of anticipation, on May 28, 2026, Representative Andy Barr (R-KY) introduced a bill to legalize and tightly regulate consumable hemp products…
DEA Application Portal for Expedited Registration of Medical Marijuana Dispensaries is Now Open
Blog April 30, 2026
As previewed in our recent blog posts (here and here), the DEA application portal for expedited registration of medical marijuana dispensaries is now open and businesses are currently able to submit applications…
Media Reports President Trump to Issue Impending Executive Order on Cannabis Rescheduling: Legal Process, Limitations, and Next Steps
Blog December 16, 2025
According to numerous media reports, President Donald Trump is strongly considering issuing an executive order directing federal agencies to resume the process rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act…
Coalition of Attorneys General Urge Congress to Tighten Definition of Hemp Under Federal Law
Blog October 31, 2025
In what has become a pivotal moment for the still nascent yet booming national market for intoxicating hemp edible products and beverages, a coalition of Attorneys General (“AG”) have called on the Congress to close the exception in the 2018 Farm Bill that enabled the proliferation of these consumer products in the past several years…
Trump Taps Controversial Florida Congressman as Attorney General Nominee
Blog November 13, 2024
In perhaps his most controversial cabinet appointment yet, earlier today, President-elect Trump said he would nominate Florida Rep. Matt Gaetz as U.S. Attorney General…
The DEA’s Rule to Reschedule Cannabis to Schedule III: Process and Timeline
Blog May 14, 2024
On April 30, 2024, the Associated Press reported the Drug Enforcement Administration will propose a rule to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act…
Between a Rock and a Hard Place: Rescheduling and the UN Single Convention on Narcotics
Blog September 06, 2023
Will the United States Attorney General, via the U.S. Drug Enforcement Administration (“DEA”) follow the recent recommendation of the U.S. Department of Health and Human Services (“HHS”) to reschedule cannabis to Schedule III?…
Bloomberg Report: HHS Recommends Marijuana Move to Schedule III
Blog August 30, 2023
Department of Health and Human Services has recommended to the U.S. Drug Enforcement Administration, to whom power is delegated under the Controlled Substances Act by the Attorney General, that cannabis be re-scheduled to Schedule III of the Controlled Substances Act…
1 of 2

About Our Blog

Foley Hoag has been at the forefront of the medical and adult-use cannabis industry since the very early stages of its regulation and legalization in specific U.S. states and beyond. Our leading, full-service Cannabis Practice is comprised of attorneys with unique insight and experience to assist cannabis and cannabis-related operators and investors with all aspects of their business. Our practice is national and international in scope, as we represent cannabis clients in transactions in a variety of states and Canada.

We have developed this blog specifically to track the regulatory framework for the cannabis industry and provide insight on legal issues of concern to cannabis businesses.

Our focus will include reporting legal developments and providing commentary on:

  • Legislative developments;
  • Regulatory and policy enactments;
  • The appointment and constitution of the Cannabis Control Commission;
  • The impact of recreational cannabis regulation on the existing medical marijuana regulatory framework;
  • Developments in federal law;
  • Municipal issues;
  • Corporate considerations;
  • Employment issues; and
  • Policy matters.